Dimopoulos Meletios A. and Moreau Philippe and Palumbo Antonio and Joshua Douglas and Pour Ludek and Hájek Roman and Facon Thierry and Ludwig Heinz and Masszi Tamás and Kollaborációs szervezet: ENDEAVOR investigators and Horváth Noémi and Egyed Miklós and Masszi Tamás and Szomor Árpád and Borbényi Zita and Illés Árpád and Kovácsovics Tibor:
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
LANCET ONCOLOGY, 17 (1).
pp. 27-38.
ISSN 1470-2045
(2016)